Youli Zu
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Viral-associated cancers and disorders
- Molecular Biology top 2%
- Advanced biosensing and bioanalysis techniques
- RNA Interference and Gene Delivery
- DNA and Nucleic Acid Chemistry
Papers in
-
- Advanced biosensing and bioanalysis techniques 36
- RNA Interference and Gene Delivery 33
- DNA and Nucleic Acid Chemistry 8
- Oncology 32
- CAR-T cell therapy research 9
- Co-authors
- Hongguang Sun (5 shared papers)Zihua Zeng (31 shared papers)Bin Hong (1 shared paper)Nianxi Zhao (16 shared papers)Roberto R. Rosato (1 shared paper)Patrick Lu (1 shared paper)Wen Tan (1 shared paper)Xun Zhu (1 shared paper)
- Journals
- Archives of Pathology & Laboratory Medicine (8 papers)Blood (5 papers)Theranostics (5 papers)Journal of Biological Chemistry (4 papers)Small (4 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Youli Zu
133 papers receiving 5.2k citations
Youli Zu's Hit Papers
Peers
Comparison fields: 5 of 126
- Oncology 1.3k
- Molecular Biology 3.1k
- Immunology 838
- Hematology 344
- Biomedical Engineering 1.2k
Countries citing papers authored by Youli Zu
This map shows the geographic impact of Youli Zu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youli Zu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youli Zu more than expected).
Fields of papers citing papers by Youli Zu
This network shows the impact of papers produced by Youli Zu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youli Zu. The network helps show where Youli Zu may publish in the future.
Co-authors
The 25 scholars most cited alongside Youli Zu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy Hit paper breakdown → | 2014 | 435 |
| 2 | Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins Hit paper breakdown → | 2013 | 384 |
| 3 | 2013 | 291 | |
| 4 | 1998 | 268 | |
| 5 | 2015 | 252 | |
| 6 | 2012 | 198 | |
| 7 | 2015 | 194 | |
| 8 | 2018 | 140 | |
| 9 | 2015 | 138 | |
| 10 | 1992 | 118 | |
| 11 | 2021 | 97 | |
| 12 | 2015 | 97 | |
| 13 | 2015 | 95 | |
| 14 | 2011 | 87 | |
| 15 | 2014 | 82 | |
| 16 | 2019 | 74 | |
| 17 | 2013 | 68 | |
| 18 | 1993 | 63 | |
| 19 | 2010 | 58 | |
| 20 | 2014 | 57 |
About Youli Zu
Youli Zu is a scholar working on Molecular Biology, Oncology, Hematology, Pathology and Forensic Medicine and Immunology, having authored 141 papers that have together received 5.2k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (36 papers), RNA Interference and Gene Delivery (33 papers), Lymphoma Diagnosis and Treatment (20 papers), Acute Myeloid Leukemia Research (14 papers), Chronic Lymphocytic Leukemia Research (11 papers), Multiple Myeloma Research and Treatments (9 papers), CAR-T cell therapy research (9 papers) and DNA and Nucleic Acid Chemistry (8 papers). The work is most often cited by research in Oncology (1.3k citations), Molecular Biology (3.1k citations), Immunology (838 citations), Hematology (344 citations) and Biomedical Engineering (1.2k citations). Youli Zu has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Hongguang Sun, Zihua Zeng, Bin Hong, Nianxi Zhao, Roberto R. Rosato, Patrick Lu, Wen Tan, Xun Zhu, Ching‐Hsuan Tung and Lidong Qin. Their work appears in journals such as Archives of Pathology & Laboratory Medicine, Blood, Theranostics, Journal of Biological Chemistry and Small.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.